QS Investors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
QS Investors's BLUE Position: Q4 2020 in Review
QS Investors sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 295 shares — an estimated $207K sold.
QS Investors first reported a position in BLUE in Q2 2016 and held it in 18 quarters. The position peaked at $1.37M in Q1 2018. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.
- QS Investors reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
- QS Investors sold 295 bluebird bio shares in Q4 2020, an estimated $207K.
- QS Investors first reported a position in bluebird bio in Q2 2016 and held it in 18 quarters.
- QS Investors's bluebird bio position peaked at $1.37M in Q1 2018.
- 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.
Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.